Press Releases Archives - Page 41 of 103 - Lupin

BSE 2273.90 NSE 2276.20

indian flag icon

India

USA

great-britain flag icon

UK

south-africa flag icon

South Africa

australia flag icon

Australia

philippines flag icon

Philippines

germany flag icon

Germany

netherlands flag icon

Netherlands

mexico flag icon

Mexico

brazil flag icon

Brazil

canada flag icon

Canada

Switzerland flag icon

Switzerland

BSE 2273.90 NSE 2276.20

Lupin Launches Leflunomide Tablets USP

September 2, 2020

Lupin and Mylan Launch Nepexto®, Biosimilar Etanercept in Germany

August 26, 2020

Lupin Receives Approval for Generic Albuterol Sulphate MDI

August 25, 2020

Lupin Presents Phase 3 Data for Solosec® (secnidazole) Demonstrating Significant Response Rate in Female Patients with Trichomoniasis

August 14, 2020

Mr. K.B.S. Anand and Dr. Punita Kumar-Sinha Join Lupin Board as Independent Directors

August 12, 2020

Lupin Launches Zileuton Extended-Release Tablets

August 11, 2020

Lupin’s Alliance Partner Concord Receives U.S. FDA Approval for Mycophenolate Mofetil Tablets USP

Lupin Signs Exclusive Distribution Pact with ForDoz Pharma for 2 Complex Injectable Assets Under Development

Lupin Quarter 1 FY2021 Results

Lupin Launches Favipiravir Drug Covihalt® for Treatment of Mild to Moderate COVID-19

1 2 … 40 41 42 … 102 103

Search

Hit enter to search or ESC to close